Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment

Core Insights - Concord Medical Services Holdings Limited announced that its subsidiary, Guangzhou Concord Cancer Center, has obtained a large medical equipment procurement license for its proton equipment, enabling it to offer proton therapy treatment services [1][2][3] Group 1: Company Developments - Guangzhou Hospital completed the installation of proton equipment in September 2020 and began clinical trials in November 2022 [2] - The National Health Commission of the PRC approved Guangzhou Hospital's application for the procurement license on September 14, 2024, allowing the hospital to start proton therapy services soon [2] - Concord Healthcare, a subsidiary of Concord Medical, also confirmed the receipt of the license for Guangzhou Hospital on September 15, 2024 [3] Group 2: Company Overview - Concord Medical provides a full cycle of premium oncology services, including cancer diagnosis, treatment, education, and prevention, focusing on multidisciplinary cancer care [4] - The company aims to enhance the quality and accessibility of cancer care through its network of self-owned and partnered hospitals across China [4] - Concord Healthcare serves cancer patients through both self-owned and third-party medical institutions, offering a comprehensive range of oncology healthcare services [5]